Can Loss of Heterozygosity Single Nucleotide Polymorphism (LOH-SNP) Profiles be used as a Prognostic Indicator of Beneficial Breast Cancer Treatment Regimens?

cited authors

  • Ramdath, Ramona S; Bazeley, Peter S; Sikanderkhel, Saad; Kalinoski, Andrea L; Allison, David Coulter